KalVista appoints Bethany Sensenig to Board and Audit Committee; annual meeting results filed

KalVista Pharmaceuticals, Inc.

Bethany Sensenig appointed to Board and Audit Committee effective October 1, 2025.
Sensenig is CFO and Head of Operations at Radius Health; former Biogen VP of Finance.
Nancy Stuart moves off Audit Committee but remains on Board and joins Compensation Committee.
Stockholders re-elected Benjamin Palleiko and Brian Pereira as Class I directors for three-year terms.
Advisory vote on named executive officer compensation passed with 33.6M shares for vs 4.0M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.